Werewolf Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(14.2%),Peter Kolchinsky(14.2%)等
Werewolf Therapeutics | 10-Q:季度報表
Werewolf Therapeutics | 8-K:Werewolf Therapeutics公佈2024年第一季度財務業績並提供業務最新情況
Werewolf Therapeutics | ARS:年度報告
Werewolf Therapeutics | DEFA14A:其他
Werewolf Therapeutics | DEF 14A:股東委託書決議
Werewolf Therapeutics | S-8:員工福利計劃證券登記
Werewolf Therapeutics | 10-K:年度報表
Werewolf Therapeutics | 8-K:Werewolf Therapeutics公佈2023年第四季度和全年財務業績並提供業務最新情況
Werewolf Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(15.2%),Peter Kolchinsky(15.2%)等
Werewolf Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-PFM Health Sciences, LP(9.6%),PFM Health Sciences GP, LLC(9.6%)等
Werewolf Therapeutics | SC 13G:超過5%持股股東披露文件-BANK OF AMERICA CORPORATION(5.8%)
Werewolf Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Rubric Capital Management LP(5.35%),David Rosen(5.35%)
Werewolf Therapeutics | 8-K:重大事件
Werewolf Therapeutics | 424B5:募資說明書
Werewolf Therapeutics | 8-K:重大事件
Werewolf Therapeutics | 4:持股變動聲明-董事 Atkins Michael B.
Werewolf Therapeutics | 3:首次持股聲明-董事 Atkins Michael B.
Werewolf Therapeutics | 8-K:重大事件
Werewolf Therapeutics | 4:持股變動聲明-高管 Trost Timothy W.
暫無數據